Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Santoro

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Scientific Reports|May 23, 2025
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STINGGiorgia Federico, Angelo Rosario Carotenuto, Arsenio Cutolo, et al.
Journal of Medicinal Chemistry|September 7, 2018
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.
Molecular and Cellular Biology|September 21, 2002
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathwayGiuliana Pelicci, Flavia Troglio, Alessandra Bodini, et al.
Neuropathology and Applied Neurobiology|July 30, 2013
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubesMassimo Santoro, Roberto Piacentini, Marcella Masciullo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
Older Adolescents Who Did or Did Not Experience COVID-19 Symptoms: Associations with Mental Health, Risk Perception and Social ConnectionJessica Burrai, Benedetta Barchielli, Clarissa Cricenti, et al.
Cancer Research|December 25, 2002
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinasesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
European Journal of Medicinal Chemistry|March 2, 2021
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluationWei Yan, Lingtian Zhang, Fengping Lv, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2005
Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinomaTeresa Guida, Giuliana Salvatore, Pinuccia Faviana, et al.
Oncogene|June 9, 2005
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumorsValentina De Falco, Valentina Guarino, Luca Malorni, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Scientific Reports|May 23, 2025
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STINGGiorgia Federico, Angelo Rosario Carotenuto, Arsenio Cutolo, et al.
Journal of Medicinal Chemistry|September 7, 2018
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.
Molecular and Cellular Biology|September 21, 2002
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathwayGiuliana Pelicci, Flavia Troglio, Alessandra Bodini, et al.
Neuropathology and Applied Neurobiology|July 30, 2013
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubesMassimo Santoro, Roberto Piacentini, Marcella Masciullo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
Older Adolescents Who Did or Did Not Experience COVID-19 Symptoms: Associations with Mental Health, Risk Perception and Social ConnectionJessica Burrai, Benedetta Barchielli, Clarissa Cricenti, et al.
Cancer Research|December 25, 2002
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinasesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
European Journal of Medicinal Chemistry|March 2, 2021
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluationWei Yan, Lingtian Zhang, Fengping Lv, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2005
Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinomaTeresa Guida, Giuliana Salvatore, Pinuccia Faviana, et al.
Oncogene|June 9, 2005
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumorsValentina De Falco, Valentina Guarino, Luca Malorni, et al.
Pageof 21